loading page

SARS CoV-2 Reinfection Across a Spectrum of Immunological States
  • +4
  • Justine McKittrick,
  • Thomas Burke,
  • Elizabeth Petzold,
  • Ephraim Tsalik,
  • Gregory Sempowski,
  • Christopher Polage,
  • Micah McClain
Justine McKittrick
Duke University School of Medicine

Corresponding Author:[email protected]

Author Profile
Thomas Burke
Duke University
Author Profile
Elizabeth Petzold
Duke University
Author Profile
Ephraim Tsalik
Duke University Medical Center
Author Profile
Gregory Sempowski
Duke Human Vaccine Institute
Author Profile
Christopher Polage
Duke University
Author Profile
Micah McClain
Duke University Medical Center
Author Profile

Abstract

Purpose: Several cases of symptomatic reinfection with SARS-CoV-2 after full recovery from a prior episode have been reported. While an uncommon phenomenon, an improved understanding of the risk factors for reinfection and the character and duration of the serological responses to infection and vaccination is critical for managing the COVID-19 pandemic. Methods: We described four cases of SARS CoV-2 reinfection in individuals representing a spectrum of healthy and immunocompromised states, including 1) a healthy 41-year-old pediatrician, 2) an immunocompromised 31-year-old with granulomatosis with polyangiitis, 3) a healthy 26-year-old pregnant woman, and 4) a 50-year-old with hypertension and hyperlipidemia. We performed confirmatory quantitative RT-PCR and qualitative IgM and quantitative IgG testing on all available patient samples to confirm the presence of infection and serological response to infection. Results: Our analysis showed that patients 1 and 2, a healthy and an immunocompromised patient, both failed to mount a robust serologic response to initial infection. In contrast, patient 3 and 4, with minimal comorbid disease, both mounted a strong serological response to their initial infection but were still susceptible to reinfection. Conclusion: Repeat episodes of COVID-19 seem capable of occurring to patients regardless of the presence of known risk factors for infection or level of serological response to infection, although this did not trigger critical illness in any instance.